QR-504a
PQ-504a-001
Phase 1 small_molecule terminated
Quick answer
QR-504a for Fuchs Endothelial Corneal Dystrophy is a Phase 1 program (small_molecule) at ProQR Therapeutics N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ProQR Therapeutics N.V.
- Indication
- Fuchs Endothelial Corneal Dystrophy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated